The Trust is led by a Board of Directors, made up of executive and non-executive members.
The Trust is led by a Board of Directors which is made up of executive and non-executive members.
Each non-executive director is a member of the local community and is appointed to bring their personal qualities and experience to the board.
The Trust Board became the Board of Directors on 1 July 2004, when the Trust formally became an NHS Foundation Trust. The role of the Board of Directors is to manage the Trust by:
The next meeting of the Board of Directors of Royal Papworth Hospital NHS Foundation Trust will be held in public on Thursday, 6 December 2018 at 9.00am in the Upper Lecture Theatre, Royal Papworth Hospital, Papworth Everard, Cambridge CB23 3RE.
Please call the Communications team on 01480 364239 if you plan to attend.
Agendas, past meeting minutes, papers and dates for future meetings can be viewed here.
The Board of Directors is made up of our Chairman, Professor John Wallwork, six other Non-executive Directors and six Executive Directors, including the Chief Executive.
The purpose of the board is to ensure high standards of clinical and corporate governance, monitor performance and ensure effective financial stewardship.
Professor Wallwork was appointed as Chairman in February 2014. He returned to Royal Papworth Hospital as Chairman after spending 30 years at the forefront of transplant surgery and research at the Trust.
Professor Wallwork is Emeritus Professor of Cardiothoracic Surgery. He was a consultant based at Papworth Hospital in Cambridge until his retirement in July 2011.
Before being appointed as a Consultant in 1981, he was Chief Resident at Stanford University Hospital in California for nearly 2 years, where he first became involved in heart and heart-lung transplantation and played a major role in the development of heart-lung transplantation at Papworth Hospital. He performed Europe’s first successful heart-lung transplant in 1984, and in 1986 he performed the world’s first heart-lung and liver transplant with Professor Sir Roy Calne.
During this period he and his colleague, Professor Tim Higenbottam, were first to introduce the use of long-term Prostacycline for Primary Pulmonary Hypertension.
In the mid 1980s he established, with Dr David White, a research bio-tech company (Imutran) to develop transgenic animals for the use of xenotransplantation in an attempt to alleviate the persistent donor organ shortage.
In 1996 he gave evidence on xenotransplantation both to the Kennedy Committee and to the United States Senate Subcommittee on Public Health and Safety.
He succeeded Sir Terence English as Director of the Transplant Service from 1989 to 2006, chaired the UK Transplant Cardiothoracic Advisory Group from 1994 to 2006 and was Medical Director of Papworth Hospital from 1997 to 2002. He was also Director of Research and Development at Papworth Hospital until his retirement.
On 1 October 2002 the University of Cambridge awarded him an honorary Chair in Cardiothoracic Surgery.
In January 2012 Professor Wallwork was recognised in Her Majesty the Queen's New Year's Honours list and was awarded a CBE for services to health.
Following 20 years of experience in the health service, spanning commissioning, provider and strategic roles, Stephen joined The Royal Papworth Hospital NHS Foundation Trust as its Chief Executive in November 2016.
Previously Stephen was the Deputy Chief Executive at East and North Hertfordshire NHS Trust where he successfully delivered a £150 million investment programme to reconfigure acute services across East and North Hertfordshire to improve clinical outcomes and enable the development of specialist services.
Stephen started his NHS leadership career at Papworth Hospital in 1998.
In addition to his role as Chief Executive, Stephen is a Director of Cambridge University Health Partners, a partnership between one of the world's leading Universities and three NHS Foundation Trusts. He also chairs the NHS England Operational Delivery Network, East.
Stephen is responsible for the development of the new state-of-the-art Royal Papworth Hospital which is due to open on the Cambridge Biomedical Campus in Spring 2019.
Oonagh joined the Trust in October 2017 having held the same role at Bedford Hospitals NHS Foundation Trust.
Oonagh worked previously at Cambridge University Teaching Hospitals, where she undertook a number of senior human resources roles including Deputy Director of Workforce.
Oonagh is originally from Northern Ireland and worked in a number of NHS organisations in Belfast before moving to Cambridge in 1993.
In 2017, Eilish joined us from East and North Hertfordshire NHS Trust, where she was the Divisional Director of Clinical Support Services. Eilish holds a wealth of experience spanning strategy, operational leadership and delivery and hospital and clinical services reconfiguration.
Eilish brings with her considerable expertise in patient safety, clinical governance and service improvement planning.
Roy was appointed Chief Finance Officer in November 2015 and has responsibility for Finance, Estates & Facilities, PFI Construction & Equipping and Commercial services. He joined the Trust from Norfolk Community Health and Care NHS Trust where he was the Director of Finance responsible for leading on all aspects of Finance, IM&T, Estates & Facilities, Procurement and Commercial Services. Previous to this role, Roy held senior roles in general acute and specialist NHS hospital services. Roy is a Chartered Management Accountant and has particular experience in developing and implementing organisational strategy, financial recovery and large scale estate development. He is motivated by developing healthcare organisations to deliver the best possible care to patients.
Roger is a consultant cardiothoracic anaesthetist and intensivist. He studied medicine at Otago University in New Zealand and completed his specialist training in the UK, New Zealand and Australia. From 1991 to 2002 he was a consultant at Green Lane Hospital in Auckland, New Zealand, practising both paediatric and adult cardiac anaesthesia and intensive care before moving to Papworth Hospital. In May 2015 he was appointed Medical Director.
Josie was appointed Director of Nursing in March 2014. She first came to Papworth in 2008 as Deputy Director of Nursing involved in introducing the Productive Ward, E-rostering and Alert Service, and then as Acting Director of Nursing from 1 July 2013.
Josie worked previously at Peterborough District Hospital as Lead Practice Development Nurse, is a Registered Nurse tutor, has a BSc in Oncology Nursing and an MSc in Nursing Practice.
Josie is the professional lead for nursing and is the Director of Infection Prevention and Control. She is also the executive lead for patient safety and the patient experience, safeguarding vulnerable people including dementia services, patient support services, clinical governance and risk management.
Andrew joins Papworth from his former role as IM & T Programme Director at Barking, Havering and Redbridge University Hospitals NHS Trust in East London. Andrew has over 20 years' experience working in the NHS and overseas within health, care and private sector. Andrew has an MSc in Healthcare Informatics and is a Fellow of the British Computer Society (BCS).
Andrew is a non-voting member of the Trust's Board of Directors.
David has experience both at Executive and Non-Executive level within the NHS. From 2007 to 2014 he was a Non-Executive Director at Guy’s and St Thomas NHS Foundation Trust where he served as Audit Chair and later as Vice Chairman of the Trust.
From 2013-2014 he was also Chairman of The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust. From 2014 to 2017 David was a Senior Director at NHS Improvement (formerly Monitor) joining initially to lead the Enforcement and later the Transformation and Turnaround teams.
Prior to his NHS career David was an Investment Banker in London and Hong Kong for 17 years and following his retirement from banking, a part-time concert pianist. He is currently Chairman of Essentia Trading Limited, a wholly-owned commercial subsidiary of Guy’s and St Thomas NHS Foundation Trust.
David is an active distance runner and completed the 250 mile Cape Wrath Ultra marathon across North West Scotland, in May 2018.
Dave had a wide-ranging executive career at BT in both CEO, CTO and most recently CIO service improvement roles. Highlights include founding BT’s Wi-Fi and Mobility businesses post the demerger of O2, building a £500m IP Network Services business during the dot com boom, and engineering delivery of BT Fusion.
Along the way he launched BT Retail broadband and voice services over the new Fibre to the premises technology, ran the consumer devices portfolio, and led the first 4G Wireless spectrum acquisition programme. He began his career with a BSc in Electrical and Electronic Engineering, has been awarded 4 patents and became a Fellow of the IET.
Dave has also been BT’s Regional Director for the East of England.
Susan was first appointed as a Non-executive Director of the Foundation Trust Board in December 2012 for a term of three years. She is currently Senior Bursar of Downing College in the University of Cambridge, a position she has held for the last 15 years after retiring from a career as an investment banker, first at The Chase Manhattan Bank in New York and then at the Chase Investment Bank in London. She is on the Board of Cambridge in America, where she holds the position of Treasurer. She is a member of the University of Cambridge Tribunal, the Nominations Committee of the Council of the University of Cambridge, and the Energy and Carbon Reduction Implementation Board. She has also chaired the University’s Board of Scrutiny, served as a member of its Audit Committee, and was Chairman of the Cambridge Colleges’ Bursars’ Committee.
Susan has extensive experience in a non-executive capacity, having served several terms on the Board of the Christ’s Hospital Foundation and chaired its Securities Investment Committee; she also has experience in estate development, fundraising, and corporate finance. She holds a PhD, and was educated at Girton College, Cambridge, the University of Kent at Canterbury, and the New York University Stern School of Business Administration.
Nick was first appointed as a Non-executive Director of the Foundation Trust Board in January 2014 for a term of three years. Nick qualified in Medicine (MB BS) from Charing Cross and Westminster Medical School (now Imperial College) in 1987. He undertook his research MD at Charing Cross and then spent two years in Denver, Colorado, as a British Heart Foundation Fellow before returning as a lecturer to complete training in general and respiratory medicine at the Royal Postgraduate Medical School, Hammersmith Hospital. He was appointed Senior Lecturer and Honorary Consultant at Hammersmith Hospital, Imperial College in 1998, and was awarded an MRC Clinician Scientist Fellowship.
He moved to Cambridge in 2000 as University Lecturer and Honorary Consultant at Addenbrooke's and Papworth hospitals, and was appointed Professor of Cardiopulmonary Medicine in 2007. In 2009 he was awarded a British Heart Foundation Professorship and was elected to the Fellowship of the Academy of Medical Sciences in 2011. He has chaired the programme committees of the British and American Thoracic Societies. He is a member of the MRC Clinical Fellowships Committee. He is Director of the BHF Cambridge Centre for Cardiovascular Research Excellence and leads the Cardiovascular Theme of the NIHR Cambridge Biomedical Research Centre. He is the Research Director of the Pulmonary Vascular Diseases Unit at Royal Papworth Hospital. His research focuses on understanding genetic causes of cardiovascular disease, particularly pulmonary arterial hypertension, and developing new treatments for these conditions.
In October 2013 he was appointed Director of Studies in Clinical Medicine at St Catharine’s College.
Ron was first appointed as a Non-executive Director of the Foundation Trust Board in December 2012 for a term of three years. He is currently Chairman of the Foundation for Genomics and Population Health, the successor to the Public Health Genetics Unit, and has a wide knowledge of local health issues having been associated in some way with the local health economy for over 35 years.
Ron graduated in 1971 following medical training at Trinity College, Cambridge and the Middlesex Hospital, London. He specialised initially in neurology and was appointed Lecturer at the Clinical School in Cambridge in 1976. He went on to obtain a law degree at Cambridge in 1983, after which he started training in public health medicine.
He was director of Public Health for Cambridge and Huntingdon Health Authority from 1991 to 1998, and Director of the Institute for Public Health of the University of Cambridge from 2002 to 2008. Prior to that he held a number of medical management positions at Addenbrooke's Hospital and as Consultant in Public Health Medicine at the Health Authority. He was for many years an Associate Lecturer at the University of Cambridge and has also been an Honorary Consultant in Public Health Medicine at Addenbrooke's Hospital.
Meetings, agendas and minutes
Our Council of Governors
Our Foundation Trust Members